TI
CKPT

tru Independence’s Checkpoint Therapeutics CKPT Stock Holding History

tru Independence’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-43,500
Closed -$1.15K – 360
2020
Q4 		$1.15K Buy
+43,500
New +$1.1M ﹤0.01% 328

Other funds holding CKPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

tru Independence's CKPT Position: Q1 2021 in Review

tru Independence sold out of Checkpoint Therapeutics (CKPT) in Q1 2021, closing a stake of 43,500 shares — an estimated $1.15K sold.

tru Independence first reported a position in CKPT in Q4 2020 and held it in 1 quarter. The position peaked at $1.15K in Q4 2020. 70 funds tracked by Wall St. Rank hold CKPT as of Q1 2021.

  • tru Independence reported no remaining Checkpoint Therapeutics position as of Q1 2021 after selling out during the quarter.
  • tru Independence sold 43,500 Checkpoint Therapeutics shares in Q1 2021, an estimated $1.15K.
  • tru Independence first reported a position in Checkpoint Therapeutics in Q4 2020 and held it in 1 quarter.
  • tru Independence's Checkpoint Therapeutics position peaked at $1.15K in Q4 2020.
  • 70 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2021.

Based on tru Independence's 13F filing for Q1 2021, filed 20 May 2021.